Zeltia Subsidiary Neuropharma Brings In EUR16M For Alzheimer's
Published: Aug 04, 2004
Neuropharma SA, a subsidiary of Zeltia Group, raised €16 million in its first external funding round to progress several preclinical programs in Alzheimer's disease.